Figure 3. Characterization of A-CIMP+ AML in the TCGA cohort.
a) Hierarchical clustering of 194 AML patient samples and 24 normal blood controls on the basis of 603 CpG sites. b) Kaplan-Meier survival analysis of 194 cases based on the clusters derived in Figure 3a. c) Clinical characteristics associated with A-CIMP+ versus A-CIMP− AML.